Moreover, high levels of CXCL12 were detected in ascitic fluid from patients with ovarian cancer [121], and some authors proposed the CXCR4/CXCL12 pair as a molecular target in ovarian cancer [127]. Here, CXCL12 is linked to ovarian carcinoma.